Biopharmaceuticals
BlueSphere Bio was founded to enable each patient’s immune system to provide the ability to create their own personal adoptive cell therapy (ACT) to treat their cancer. Our vision is for every cancer patient to have a chance for a cure.
Our novel technology unlocks the potential of individualized T-cell therapy for the treatment of cancer by harnessing the specificity of each patient’s T cells for the unique molecular fingerprint of their own cancer.
Mark Shlomchik, M.D., Ph.D.
David Apelian, Ph.D., M.D.,
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.